Seligson & Co Rahastoyhtiö Oyj
Seligson & Co Fund Management Company Plc
STOCK EXCHANGE NOTICE 25 March 2021
SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: ANNUAL REPORT, BOARD OF THE MANAGEMENT COMPANY AND AUDITOR
The Annual Report of Seligson & Co OMX Helsinki 25 Exchange Traded Fund UCITS ETF, dated 31 December 2020, has been published. The report, which is in Finnish, forms part (pages 24 to 27) of the attached common Annual Report for all the funds managed by Seligson & Co Fund Management Company. The report includes the Auditor's Report, and it is also available at www.seligson.fi/sco/suomi/esitteet/.
The following members were elected to the board of Seligson & Co Fund Management Company Plc at the Annual General Meeting held on 25 March 2021: Samu Anttila, Jarkko Niemi and Mikko Vasko. KPMG Plc was chosen as the auditor and CPA Marcus Tötterman as the deputy auditor.
Further information:
Mari Rautanen
email: mari.rautanen@seligson.fi
Phone +358 (0)9 6817 8224
Seligson & Co Fund Management Company Plc
Ari Kaaro
Managing Director
email: ari.kaaro@seligson.fi
Phone +358 (0)9 6817 8217
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
